Home/Filings/4/0001562180-19-001033
4//SEC Filing

Kanes Stephen 4

Accession 0001562180-19-001033

CIK 0001597553other

Filed

Feb 14, 7:00 PM ET

Accepted

Feb 15, 4:32 PM ET

Size

5.6 KB

Accession

0001562180-19-001033

Insider Transaction Report

Form 4
Period: 2019-02-13
Kanes Stephen
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2019-02-13+19,00019,000 total
    Exercise: $157.63Exp: 2029-02-13Common Stock (19,000 underlying)
Footnotes (1)
  • [F1]The securities awarded on February 13, 2019 were in the form of stock options issued pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. Options to purchase 4,750 shares of common stock shall vest on the one year anniversary of February 13, 2019, with 14,250 shares vesting in 36 equal monthly installments thereafter.

Issuer

Sage Therapeutics, Inc.

CIK 0001597553

Entity typeother

Related Parties

1
  • filerCIK 0001612859

Filing Metadata

Form type
4
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 4:32 PM ET
Size
5.6 KB